{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:07:58Z","timestamp":1794258478427,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral small vessel disease (CSVD) plays an important role in cognitive impairment, stroke, disability, and death. Hypertension is the main risk factor for CSVD. The use of antihypertensive therapy has not resulted in the expected decrease in CSVD complications, which may be related to the underestimation of significance of daily blood pressure profile for blood\u2013brain barrier (BBB) permeability. 53 patients with CSVD of varying severity (mean age 60.08\u2009\u00b1\u20096.8\u00a0years, 69.8% women, subjects with treated long-standing hypertension vs. normotensive subjects\u2009\u2212\u200984.8% vs. 15.2%) and 17 healthy volunteers underwent ambulatory blood pressure monitoring (ABPM) and MRI, including T1-weighted dynamic\u00a0contrast-enhanced\u00a0magnetic resonance imaging for assessing BBB permeability. Most of ABPM parameters in CSVD patients did not differ from controls, but were associated with the severity of white matter hyperintensity (WMH) and the total CSVD score. BBB permeability in normal-appearing white matter (NAWM) and grey matter (GM) was significantly higher in CSVD patients, and the severity of BBB permeability remained similar in patients with different stages of WMH. Among BBB permeability parameters, the area under the curve, corresponding to an increase in the contrast transit time in NAWM, had the greatest number of correlations with deviations of ABPM parameters. BBB permeability in CSVD is a universal mechanism of NAWM and GM damage associated with a slight increase in ABPM parameters. It is obvious that the treatment of hypertension in patients with not severe WMH should be more aggressive and carried out under the control of ABPM.<\/jats:p>","DOI":"10.1038\/s41598-022-11172-1","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T09:09:42Z","timestamp":1652260182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Daily blood pressure profile and blood\u2013brain barrier permeability in patients with cerebral small vessel disease"],"prefix":"10.1038","volume":"12","author":[{"given":"L. A.","family":"Dobrynina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V.","family":"Shamtieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. I.","family":"Kremneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Zabitova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Akhmetzyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Gnedovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Krotenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"issue":"9","key":"11172_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick, P. B. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42(9), 2672\u20132713. https:\/\/doi.org\/10.1161\/STR.0b013e3182299496 (2011).","journal-title":"Stroke"},{"key":"11172_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","volume":"78","author":"V Deramecourt","year":"2012","unstructured":"Deramecourt, V. et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology 78, 1043\u20131050. https:\/\/doi.org\/10.1212\/WNL.0b013e31824e8e7f (2012).","journal-title":"Neurology"},{"issue":"2","key":"11172_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jalz.2017.07.755","volume":"14","author":"MR Azarpazhooh","year":"2018","unstructured":"Azarpazhooh, M. R. et al. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Demen. 14(2), 148\u2013156. https:\/\/doi.org\/10.1016\/j.jalz.2017.07.755 (2018).","journal-title":"Alzheimers Demen."},{"key":"11172_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1212\/wnl.56.7.921","volume":"56","author":"C Dufouil","year":"2001","unstructured":"Dufouil, C. et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI cohort. Neurology 56, 921\u2013926. https:\/\/doi.org\/10.1212\/wnl.56.7.921 (2001).","journal-title":"Neurology"},{"key":"11172_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/awf077","volume":"125","author":"FE de Leeuw","year":"2002","unstructured":"de Leeuw, F. E. et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125, 765\u2013772. https:\/\/doi.org\/10.1093\/brain\/awf077 (2002).","journal-title":"Brain"},{"key":"11172_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw, J. M., Smith, C. & Dichgans, M. Mechanisms underlying sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 12, 483\u2013497. https:\/\/doi.org\/10.1016\/S1474-4422(13)70060-7 (2013).","journal-title":"Lancet Neurol."},{"issue":"5","key":"11172_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/01.HYP.0000145857.98904.20","volume":"44","author":"EJ van Dijk","year":"2004","unstructured":"van Dijk, E. J. et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 44(5), 625\u2013630. https:\/\/doi.org\/10.1161\/01.HYP.0000145857.98904.20 (2004).","journal-title":"Hypertension"},{"issue":"1","key":"11172_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00685305","volume":"12","author":"CM Fisher","year":"1969","unstructured":"Fisher, C. M. The arterial lesions underlying lacunes. Acta Neuropathol. 12(1), 1\u201315. https:\/\/doi.org\/10.1007\/BF00685305 (1969).","journal-title":"Acta Neuropathol."},{"issue":"1","key":"11172_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12916-016-0676-5","volume":"14","author":"KE McAleese","year":"2016","unstructured":"McAleese, K. E. et al. Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med. 14(1), 129. https:\/\/doi.org\/10.1186\/s12916-016-0676-5 (2016).","journal-title":"BMC Med."},{"issue":"9","key":"11172_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1751-7176.2011.00530.x","volume":"13","author":"H Arima","year":"2011","unstructured":"Arima, H. & Chalmers, J. PROGRESS: prevention of recurrent stroke. J. Clin. Hypertens. 13(9), 693\u2013702. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00530.x (2011).","journal-title":"J. Clin. Hypertens."},{"issue":"5","key":"11172_CR11","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/S2214-109X(13)70095-0","volume":"1","author":"GJ Hankey","year":"2013","unstructured":"Hankey, G. J. The global and regional burden of stroke. Lancet Glob. Health 1(5), e239\u2013e240. https:\/\/doi.org\/10.1016\/S2214-109X(13)70095-0 (2013).","journal-title":"Lancet Glob. Health"},{"issue":"9","key":"11172_CR12","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/STROKEAHA.111.648576","volume":"43","author":"R Weber","year":"2012","unstructured":"Weber, R. et al. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke 43(9), 2336\u20132342. https:\/\/doi.org\/10.1161\/STROKEAHA.111.648576 (2012).","journal-title":"Stroke"},{"issue":"6","key":"11172_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","volume":"321","author":"JD Williamson","year":"2019","unstructured":"Williamson, J. D. et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 321(6), 553\u2013561. https:\/\/doi.org\/10.1001\/jama.2018.21442 (2019).","journal-title":"JAMA"},{"issue":"6","key":"11172_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/ijo.2017.57","volume":"41","author":"JCL Mamo","year":"2017","unstructured":"Mamo, J. C. L. et al. Antihypertensive agents do not prevent blood-brain barrier dysfunction and cognitive deficits in dietary-induced obese mice. Int. J. Obes. 41(6), 926\u2013934. https:\/\/doi.org\/10.1038\/ijo.2017.57 (2017).","journal-title":"Int. J. Obes."},{"issue":"17","key":"11172_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/WNR.0000000000000464","volume":"26","author":"Y Fan","year":"2015","unstructured":"Fan, Y. et al. Tight junction disruption of blood-brain barrier in white matter lesions in chronic hypertensive rats. Neuroreport 26(17), 1039\u20131043. https:\/\/doi.org\/10.1097\/WNR.0000000000000464 (2015).","journal-title":"Neuroreport"},{"issue":"6","key":"11172_CR16","doi-asserted-by":"publisher","first-page":"001140","DOI":"10.1161\/JAHA.114.001140","volume":"4","author":"JM Wardlaw","year":"2016","unstructured":"Wardlaw, J. M., Vald\u00e9s Hern\u00e1ndez, M. C. & Mu\u00f1oz-Maniega, S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J. Am. Heart Assoc. 4(6), 001140. https:\/\/doi.org\/10.1161\/JAHA.114.001140 (2016).","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"11172_CR17","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"C Iadecola","year":"2016","unstructured":"Iadecola, C. et al. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension 68(6), e67\u2013e94. https:\/\/doi.org\/10.1161\/HYP.0000000000000053 (2016).","journal-title":"Hypertension"},{"issue":"10","key":"11172_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41371-020-0352-2","volume":"34","author":"V Katsi","year":"2020","unstructured":"Katsi, V. et al. Blood\u2013brain barrier dysfunction: the undervalued frontier of hypertension. J. Hum. Hypertens. 34(10), 682\u2013691. https:\/\/doi.org\/10.1038\/s41371-020-0352-2 (2020).","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"11172_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","volume":"63","author":"VC Biancardi","year":"2014","unstructured":"Biancardi, V. C., Son, S. J., Ahmadi, S., Filosa, J. A. & Stern, J. E. Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood\u2013brain barrier. Hypertension 63(3), 572\u2013579. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01743 (2014).","journal-title":"Hypertension"},{"key":"11172_CR20","first-page":"359","volume":"20","author":"AF Hazama","year":"1978","unstructured":"Hazama, A. F., Amano, S. & Ozaki, T. Pathological changes of cerebral vessel endothelial cells in spontaneously hypertensive rats, with special reference to the role of these cells in the development of hypertensive cerebrovascular lesions. Adv. Neurol. 20, 359\u2013369 (1978).","journal-title":"Adv. Neurol."},{"issue":"6","key":"11172_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola, C. & Davisson, R. L. Hypertension and cerebrovascular dysfunction. Cell Metab. 7(6), 476\u2013484. https:\/\/doi.org\/10.1016\/j.cmet.2008.03.010 (2008).","journal-title":"Cell Metab."},{"issue":"1","key":"11172_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2040-7378-5-4","volume":"5","author":"S Schreiber","year":"2013","unstructured":"Schreiber, S., Bueche, C. Z., Garz, C. & Braun, H. Blood brain barrier breakdown as the starting point of cerebral small vessel disease?\u2014New insights from a rat model. Exp. Transl. Stroke Med. 5(1), 4. https:\/\/doi.org\/10.1186\/2040-7378-5-4 (2013).","journal-title":"Exp. Transl. Stroke Med."},{"issue":"1","key":"11172_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/STROKEAHA.119.026739","volume":"51","author":"Y Ma","year":"2020","unstructured":"Ma, Y. et al. Blood pressure variability and cerebral small vessel disease: a systematic review and meta-analysis of population-based cohorts. Stroke 51(1), 82\u201389. https:\/\/doi.org\/10.1161\/STROKEAHA.119.026739 (2020).","journal-title":"Stroke"},{"issue":"1","key":"11172_CR24","doi-asserted-by":"publisher","first-page":"e013841","DOI":"10.1161\/JAHA.119.013841","volume":"9","author":"PJ Tully","year":"2020","unstructured":"Tully, P. J. et al. Association between blood pressure variability and cerebral small-vessel disease: a systematic review and meta-analysis. J. Am. Heart Assoc. 9(1), e013841. https:\/\/doi.org\/10.1161\/JAHA.119.013841 (2020).","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"11172_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jalz.2016.09.006","volume":"13","author":"JM Wardlaw","year":"2017","unstructured":"Wardlaw, J. M. et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimers Dement. 13(6), 634\u2013643. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.006 (2017).","journal-title":"Alzheimers Dement."},{"issue":"6","key":"11172_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","volume":"15","author":"MJ Thrippleton","year":"2019","unstructured":"Thrippleton, M. J. et al. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations. Alzheimers Dement. 15(6), 840\u2013858. https:\/\/doi.org\/10.1016\/j.jalz.2019.01.013 (2019).","journal-title":"Alzheimers Dement."},{"issue":"2","key":"11172_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/jnnp.2009.172072","volume":"81","author":"R Topakian","year":"2010","unstructured":"Topakian, R., Barrick, T. R., Howe, F. A. & Markus, H. S. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J. Neurol. Neurosurg. Psychiatry 81(2), 192\u2013197. https:\/\/doi.org\/10.1136\/jnnp.2009.172072 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"11172_CR28","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1161\/STROKEAHA.115.009589","volume":"46","author":"BN Huisa","year":"2015","unstructured":"Huisa, B. N. et al. Long-term blood-brain barrier permeability changes in binswanger disease. Stroke 46(9), 2413\u20132418. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009589 (2015).","journal-title":"Stroke"},{"issue":"8","key":"11172_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw, J. M. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12(8), 822\u2013838. https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8 (2013).","journal-title":"Lancet Neurol."},{"issue":"3","key":"11172_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7(3), 270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008 (2011).","journal-title":"Alzheimers Dement."},{"issue":"3","key":"11172_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.00","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7(3), 263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.00 (2011).","journal-title":"Alzheimers Dement."},{"issue":"9","key":"11172_CR32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","volume":"31","author":"E O\u2019Brien","year":"2013","unstructured":"O\u2019Brien, E. et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J. Hypertens. 31(9), 1731\u20131768. https:\/\/doi.org\/10.1097\/HJH.0b013e328363e964 (2013).","journal-title":"J. Hypertens."},{"issue":"7","key":"11172_CR33","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia, G. et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens. 31(7), 1281\u20131357. https:\/\/doi.org\/10.1097\/01.hjh.0000431740.32696.cc (2013).","journal-title":"J Hypertens."},{"issue":"11","key":"11172_CR34","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1161\/STROKEAHA.113.002545","volume":"44","author":"P Klarenbeek","year":"2013","unstructured":"Klarenbeek, P., van Oostenbrugge, R. J., Rouhl, R. P., Knottnerus, I. L. & Staals, J. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease. Stroke 44(11), 2995\u20132999. https:\/\/doi.org\/10.1161\/STROKEAHA.113.002545 (2013).","journal-title":"Stroke"},{"issue":"10","key":"11172_CR35","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.neurobiolaging.2015.06.024","volume":"36","author":"J Staals","year":"2015","unstructured":"Staals, J. et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol. Aging 36(10), 2806\u20132811. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.06.024 (2015).","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"11172_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2214\/ajr.149.2.351","volume":"8","author":"F Fazekas","year":"1987","unstructured":"Fazekas, F. et al. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am. J. Roentgenol. 8(3), 421\u2013426. https:\/\/doi.org\/10.2214\/ajr.149.2.351 (1987).","journal-title":"AJR Am. J. Roentgenol."},{"issue":"6","key":"11172_CR37","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1212\/WNL.0000000000005948","volume":"91","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Hemodynamic assessments of venous pulsatile tinnitus using 4D-flow MRI. Neurology. 91(6), e586\u2013e593. https:\/\/doi.org\/10.1212\/WNL.0000000000005948 (2018).","journal-title":"Neurology."},{"issue":"3","key":"11172_CR38","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.STR.0000058480.77236.B3","volume":"34","author":"JM Wardlaw","year":"2003","unstructured":"Wardlaw, J. M., Sandercock, P. A., Dennis, M. S. & Starr, J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 34(3), 806\u2013812. https:\/\/doi.org\/10.1161\/01.STR.0000058480.77236.B3 (2003).","journal-title":"Stroke"},{"issue":"7","key":"11172_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/jcbfm.2011.197","volume":"32","author":"GA Rosenberg","year":"2012","unstructured":"Rosenberg, G. A. Neurological diseases in relation to the blood-brain barrier. J. Cereb. Blood Flow Metab. 32(7), 1139\u20131151. https:\/\/doi.org\/10.1038\/jcbfm.2011.197 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"448","key":"11172_CR40","doi-asserted-by":"publisher","first-page":"eaam507","DOI":"10.1126\/scitranslmed.aam9507","volume":"10","author":"RM Rajani","year":"2018","unstructured":"Rajani, R. M. et al. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats. Sci. Transl. Med. 10(448), eaam507. https:\/\/doi.org\/10.1126\/scitranslmed.aam9507 (2018).","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"11172_CR41","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s00415-017-8550-8","volume":"264","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Higher blood\u2013brain barrier permeability is associated with higher white matter hyperintensities burden. J. Neurol. 264(7), 1474\u20131481. https:\/\/doi.org\/10.1007\/s00415-017-8550-8 (2017).","journal-title":"J. Neurol."},{"key":"11172_CR42","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.31.1_supplement.1010.5","author":"A Setiadi","year":"2017","unstructured":"Setiadi, A., May, C. N. & Yao, S. T. Ablation of astrocytes in the paraventricular nucleus disrupts the blood-brain barrier and increases blood pressure in rats. FASEB J. https:\/\/doi.org\/10.1096\/fasebj.31.1_supplement.1010.5 (2017).","journal-title":"FASEB J."},{"issue":"6","key":"11172_CR43","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1161\/HYPERTENSIONAHA.112.200972","volume":"61","author":"D Tryambake","year":"2013","unstructured":"Tryambake, D. et al. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension 61(6), 1309\u20131315. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.200972 (2013).","journal-title":"Hypertension"},{"issue":"22","key":"11172_CR44","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"SPRINT Research Group","year":"2015","unstructured":"SPRINT Research Group et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373(22), 2103\u20132116. https:\/\/doi.org\/10.1056\/NEJMoa1511939 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"11172_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/eurheartj\/ehv633","volume":"37","author":"G Mancia","year":"2016","unstructured":"Mancia, G. et al. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Eur. Heart J. 37(12), 955\u2013964. https:\/\/doi.org\/10.1093\/eurheartj\/ehv633 (2016).","journal-title":"Eur. Heart J."},{"issue":"6","key":"11172_CR46","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a Report of the American College of Cardiology\/American heart Association. Task force on clinical practice guidelines. Hypertension 71(6), 1269\u20131324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066 (2018).","journal-title":"Hypertension"},{"issue":"6","key":"11172_CR47","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/jamaneurol.2017.5153","volume":"75","author":"ID Croall","year":"2018","unstructured":"Croall, I. D. et al. Effect of standard vs intensive blood pressure control on cerebral blood flow in small vessel disease: the preserve randomized clinical trial. JAMA Neurol. 75(6), 720\u2013727. https:\/\/doi.org\/10.1001\/jamaneurol.2017.5153 (2018).","journal-title":"JAMA Neurol."},{"issue":"2","key":"11172_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","volume":"64","author":"RA Whitmer","year":"2005","unstructured":"Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C. & Yaffe, K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64(2), 277\u2013281. https:\/\/doi.org\/10.1212\/01.WNL.0000149519.47454.F2 (2005).","journal-title":"Neurology"},{"issue":"6","key":"11172_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2019.10575","volume":"322","author":"KA Walker","year":"2019","unstructured":"Walker, K. A. et al. Association of midlife to late-life blood pressure patterns with incident dementia. JAMA 322(6), 535\u2013545. https:\/\/doi.org\/10.1001\/jama.2019.10575 (2019).","journal-title":"JAMA"},{"issue":"2","key":"11172_CR50","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/STROKEAHA.115.009627","volume":"47","author":"M Ihara","year":"2016","unstructured":"Ihara, M. & Yamamoto, Y. Emerging evidence for pathogenesis of sporadic cerebral small vessel disease. Stroke 47(2), 554\u2013560. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009627 (2016).","journal-title":"Stroke"},{"issue":"6","key":"11172_CR51","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/ijms21062036","volume":"21","author":"LA Dobrynina","year":"2020","unstructured":"Dobrynina, L. A. et al. The predictive value of salt sensitivity and osmotic fragility in the development of cerebral small vessel disease. Int. J. Mol. Sci. 21(6), 2036. https:\/\/doi.org\/10.3390\/ijms21062036 (2020).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11172-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:03:24Z","timestamp":1669327404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11172"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11172-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1332879\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"6 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7723"}}